Evidence map›Paper›PMID 32015048›Full record

ArticleAntimicrobial agents and chemotherapy2020

Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.

Ruta Petraitiene, Vidmantas Petraitis, Povilas Kavaliauskas, Bo Bo W Maung, Farehin Khan, Ethan Naing, Thein Aung, Vilma Zigmantaite, Ramune Grigaleviciute, Audrius Kucinskas and 6 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Bacteriophage treatment is effective against carbapenem-resistantAntimicrobial agents and chemotherapy · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Ruta PetraitieneTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA rop2016@med.cornell.edu.
Vidmantas PetraitisTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Povilas KavaliauskasTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Bo Bo W MaungTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Farehin KhanTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Ethan NaingTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Thein AungTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Vilma ZigmantaiteLithuanian University of Health Sciences, Biological Research Center, Kaunas, Lithuania.
Ramune GrigaleviciuteLithuanian University of Health Sciences, Biological Research Center, Kaunas, Lithuania.
Audrius KucinskasLithuanian University of Health Sciences, Biological Research Center, Kaunas, Lithuania.
Rimantas StakauskasLithuanian University of Health Sciences, Biological Research Center, Kaunas, Lithuania.
Benjamin N GeorgiadesAllergan Inc., Irvine, California, USA.
Chase A MazurDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Joshua A HaydenDepartment of Pathology and Laboratory Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Michael J SatlinTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Thomas J WalshTransplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, New York, New York, USA.
Cornell University · USLithuanian University of Health Sciences · LTAllergan (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Bacterial AgentsAzabicyclo CompoundsBacteremiaBacterial LoadBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCeftazidimeDrug CombinationsDrug Resistance, Multiple, BacterialFemaleKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasescarbapenemaseCeftazidimeDrug Combinationsceftazidime-avibactam (CZA)Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-Kp)pharmacokineticspneumoniarabbits

Identifiers

PMID32015048
PMCPMC7179283
OpenAlexW3003612946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.